ApoE is a mediator in pathways underlying neurodegeneration decline, which makes it a therapeutic target for AD and related dementias. In the article, it appears that converting ApoE4 to ApoE3 attenuate Aβ pathology, improving astrocyts and microglia-RN ht
RT @Angelin53701956: Dysfunction of synapses, #neurodegeneration, neuroinflammation, and vascular dysfunction are all present at the cellul…
Dysfunction of synapses, #neurodegeneration, neuroinflammation, and vascular dysfunction are all present at the cellular level in #Alzheimers disease. https://t.co/9Ca4R8wsDs @Angelin53701956
We've detected a paper from Molecular Neurodegeneration that cites a retracted paper post-retraction. Citing paper: https://t.co/8PAfns2GPH Retracted paper: https://t.co/g2N45AEbPT